Nexam Chemical: Big potential but it comes at a cost - ABG

Near-term headwinds, long-term growth potential intact
Unused credit facility of SEK 11.5m & cash position of SEK 23m
The share is trading at 20x EV/EBITDA on 2024e


Q4'22 results

Nexam had Q4 sales of SEK 56m (ABGSCe SEK 62m). The company did not, as we had expected, see a recovery in its PET foam additive sales. This resulted in group EBITDA of SEK -1m and a net profit of SEK -5m.

Länk till analysen i sin helhet: https://cr.abgsc.com/foretag/nexam-chemical/Equity-research/2023/1/nexam-chemical---big-potential-but-it-comes-at-a-cost/